BASi Announces John B. Landis, Ph.D. Elected to Board
© Marketwire 2009
18.11.2009 22:11:02
|
|
Board of Directors of the Company.
Dr. Landis retired from his position as Senior Vice President,
Pharmaceutical Sciences of Schering-Plough in October 2008 and is currently
an Adjunct Professor at Purdue University's Department of Chemistry. Prior
to joining Schering-Plough in 2003, Dr. Landis served in various management
positions with Pharmacia Corporation and The Upjohn Company, including
Director of Quality Control, Executive Director of Quality Control, Vice
President of Quality Control, Vice President of Analytical Research, Vice
President of CNS Psychiatry, and Senior Vice President of Preclinical
Development.
"We are very pleased John will be joining the Board. He has broad
scientific and industry experience and his knowledge and insights will
provide a valuable perspective to our Board," said BASi Board Chairman
William E. Baitinger.
Dr. Landis received his Bachelor of Science in Chemistry from Kent State
University, his Masters in Analytical Chemistry from Purdue University and
his Ph.D. in Analytical Chemistry from Purdue University.
BASi is a pharmaceutical development company providing contract research
services and monitoring instruments to the world's leading drug development
companies and medical research organizations. The company focuses on
developing innovative services and products that increase efficiency and
reduce the cost of taking a new drug to market. Visit www.BASInc.com : www.BASInc.com for
more information about BASi.
This release may contain forward-looking statements that are subject to
risks and uncertainties including, but not limited to, those market and
operating risks detailed in the company's filings with the Securities and
Exchange Commission.
